Modulation of doxorubicin cytotoxicity by ethacrynic acid

International Journal of Cancer

Volumn 68, Issue 3, 1996, Pages 333-339

  Awasthi, Sanjay ^a   Singhal, Sharad S ^a,b   Nong gao, H E ^b   Chaubey, Meena ^b   Zimniak, Piotr ^c   Srivastava, Sanjay K ^d   Singh, Shivendra V ^d   Awasthi, Yogesh C ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d MERCY HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ETACRYNIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; DRUG TRANSPORT; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CARCINOMA, SMALL CELL; CELL MEMBRANE; DIURETICS; DOXORUBICIN; DRUG INTERACTIONS; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; ETHACRYNIC ACID; GLUTATHIONE; HUMANS; LUNG NEOPLASMS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; TUMOR CELLS, CULTURED;

EID: 0029806273     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961104)68:3<333::AID-IJC11>3.0.CO;2-9     Document Type: Article

References (18)

1. AWASTHI, S., SlNGHAL, S.S., SRIVASTAVA, S.K., ZlMNIAK, P., BAJPAI, K.K., SAXENA, M., SHARMA, R., ZILLER, S.A., FRENKEL, E.P., SINGH, S.V., HE, N.G. and AWASTHI, Y.C., Adenosine triphosphate-dependent transport of doxorubicin, daunomycin, and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein. J. clin. Invest., 93, 958-965 (1994).
2. AWASTHI, S., SRIVASTAVA, S.K., AHMAD, F., AHMAD, H. and ANSARI, G.A.S., Interactions of glutathione S-transferase π with ethacrynic acid and its glutathione conjugate. Biochim. Biophys. Acta, 1164, 173-178 (1993).
3. BIEDLER, J.L., Genetic aspects of multidrug resistance. Cancer, 70, 1799-1809 (1992).
4. BOARD, P.G., Inhibition of erythrocyte-glutathione-conjugate transport by polyethoxylated surfactants. FEBS Lett., 315, 298-300 (1993).
5. BREUNINGER, L.M, PAUL, S., GAUGHAN, K., MIKI, T., CHAN, A., AARONSON, S.A. and KRUH, G.D., Expression of multidrug-resistanceassociated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res., 55, 5342-5347 (1995).
6. ELLMAN, G.L., COURTNEY, K.D., ANDRES, V. and FEATHERSTONE, R.M., A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol., 7, 88-95 (1961).
7. HE, N.G., SRIVASTAVA, S.K., CHALIBEY, M., SINGHAL, S.S., HERZOG, N.K. and AWASTHI, S., An inverse relationship between expression of GST-π and doxorubicin resistance in a series of doxorubicm-resistant sub-lines of the NCI-H69 human small-cell-lung-cancer cell lines. Biochem. Arch., 11, 9-19 (1995).
8. HORIO, M.M., GOTTESMAN, M.M. and PASTAN, I., ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc. not. Acad. Sci. (Wash.), 85, 3580-3584 (1988).
9. JULIANO, R.L. and LING, V., A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. biophys. Acta, 455, 152-162 (1976).
10. LEGHA, S.S., BENJAMIN, R.S., MACKAY, B., EWER, M., WALLACE, S., VALDIVIESO, M., RASMUSSEN, S.L., BLUMENSCHEIN, G.R. and FREIREICH, E.J., Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann. intern. Med., 96, 133-139 (1982).
11. MULLER, M., MEIJER, C., ZAMAN, G.J., BORST, P., SCHEPER, R.J., MULDER, N.H., DE VRIES, E.G. and JANSEN, P.L., Over-expression of the gene encoding the multidrug-resistance-assodated protein results in increased ATP-dependent glutathione S-conjugates transport. Proc. nat. Acad. Sci. (Wash.), 20, 13033-13037 (1994).
12. O'DWYER, P.J., LACRETA, F., NASH, S., TINSLEY, P.W., SCHILDER, R., CLAPPER, M.L., TEW, K.D., PANTING, L., LITWIN, S., COMIS, R.L. and OZOLS, R.F., Phase-I study of thiotepa in combination with the glutathione-transferase inhibitor ethacrynic acid. Cancer Res., 51, 6059-6065 (1991).
13. RONINSON, I.E., CHIN, J.E., CHOI, K., GROS, P., HOUSEMAN, D.E., FOJO, A., SHEN, D.W., GOTTESMAN, M.M. and PASTAN, I., Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc. nat. Acad. Sci. (Wash.), 83, 4583-4590 (1986).
14. STECK, T.L. and KANT, J.A., Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Meth. Enzymol., 31A, 172-180 (1974).
15. STEEL, G.G. and PECKHAM, M.J., Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int. J. Rad. Oncol. Biol. Phys., 5, 85-91 (1979).
16. TEW, K.D., BOMBER, A.M. and HOFFMAN, S.J., Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug-resistant and -sensitive cell lines. Cancer Res.. 48, 3622-3625 (1988).
17. WAXMANN, D.J., Glutathione S-transferases: role in alkylating-agent resistance and possible target for modulation chemotherapy - a review. Cancer Res., 50, 6449-6454 (1990).
18. WINTER, C.G., DELUCA, D.C. and SZUMILO, H., 2,4-dinitrophenol and carbonylcyanide p-trifluoromethoxyphenylhydrazone activate the glutathione-S-conjugate transport ATPase of human erythrocyte membranes. Arch. Biochem. Biophys., 314, 17-22 (1994).